Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AUT00063 vs placebo for subjective tinnitus (Phase IIa)
2014-002179-27Phase 2Terminated
- Sponsor
- Autifony Therapeutics
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in tinnitus comparing AUT00063 arm with Placebo arm (2 arms). Primary endpoint: Change in TFI overall score at Day 28. Started Jul 2014; status: terminated.
02
Drugs
AUT00063
03
Conditions
tinnitus
Beyond the preview
Go deeper on 2014-002179-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002179-27.